Edition:
United Kingdom

HPGC Renmintongtai Pharmaceutical Corp (600829.SS)

600829.SS on Shanghai Stock Exchange

12.24CNY
--
Change (% chg)

-- (--)
Prev Close
¥12.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
¥16.06
52-wk Low
¥11.60

Chart for

About

HPGC Renmintongtai Pharmaceutical Corporation, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., is a China-based company, principally engaged in the wholesale and retail of pharmaceuticals. The Company principally engages in the sales of Chinese medicines and western drugs. It also engages in the sales... (more)

Overall

Beta: 1.43
Market Cap(Mil.): ¥7,097.84
Shares Outstanding(Mil.): 579.89
Dividend: 0.50
Yield (%): 4.08

Financials

  Industry Sector
P/E (TTM): -- 20.98 16.64
EPS (TTM): -- -- --
ROI: -- 11.72 10.66
ROE: -- 13.91 14.30

BRIEF-Citic Capital To Become HPGC Renmintongtai Pharmaceutical's Owner After Stake Deals

* SAYS CITIC CAPITAL INVESTMENT FUND PLANS TO INVEST 1.5 BILLION YUAN ($228.87 million) IN CONTROLLING SHAREHOLDER HARBIN PHARMACEUTICAL GROUP

27 Dec 2017

BRIEF-HPGC Renmintongtai's board elects chairman

* SAYS BOARD ELECTS ZHANG ZHENPING AS CHAIRMAN Source text in Chinese: http://bit.ly/2AdOvPm Further company coverage: (Reporting by Hong Kong newsroom)

29 Nov 2017

BRIEF-HPGC Renmintongtai Pharma's share trade to halt from Sept 28 pending announcement

Sept 27 HPGC Renmintongtai Pharmaceutical Corp * Says share trade to halt from Sept 28 pending announcement Source text in Chinese: http://bit.ly/2hvCOMr Further company coverage: (Reporting by Hong Kong newsroom)

27 Sep 2017

Earnings vs. Estimates